Literature DB >> 1670799

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan.

T D Mastro1, A Ghafoor, N K Nomani, Z Ishaq, F Anwar, D M Granoff, J S Spika, C Thornsberry, R R Facklam.   

Abstract

87 strains of Streptococcus pneumoniae isolated during three winter seasons (1986-89) from the blood of children with acute lower respiratory tract infection (ALRI) in Pakistan were serotyped and tested for susceptibility to a range of antimicrobial agents. 97% of isolates were resistant to at least one antimicrobial drug. 62% had decreased susceptibility to co-trimoxazole (trimethoprim/sulphamethoxazole) (31% were fully resistant) and 39% were resistant to chloramphenicol. All isolates were susceptible to erythromycin, cefaclor, cephalothin, ceftriaxone, cefuroxime, rifampicin, vancomycin, and clindamycin. 29% of isolates were neither vaccine types nor vaccine-related types. Serotype distribution and antimicrobial susceptibility varied significantly during the three winter seasons. No single serotype was found in all three winters. The findings highlight the need for surveillance of antimicrobial resistance and serotype distribution of S pneumoniae in developing countries as a guide both to the choice of agent for treatment of pneumococcal infections, especially ALRI, and to the formulation of new pneumococcal conjugate vaccines for use in young children.

Entities:  

Mesh:

Year:  1991        PMID: 1670799     DOI: 10.1016/0140-6736(91)90813-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

1.  Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995.

Authors:  S K Saha; N Rikitomi; D Biswas; K Watanabe; M Ruhulamin; K Ahmed; M Hanif; K Matsumoto; R B Sack; T Nagatake
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan.

Authors: 
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

Review 3.  Middle ear effusion in children.

Authors:  A T Cheng; N M Young
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

4.  Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents.

Authors:  C M Parry; T S Diep; J Wain; N T Hoa; M Gainsborough; D Nga; C Davies; N H Phu; T T Hien; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Comparison of goat and horse blood as culture medium supplements for isolation and identification of Haemophilus influenzae and Streptococcus pneumoniae from upper respiratory tract secretions.

Authors:  M Gratten; D Battistutta; P Torzillo; J Dixon; K Manning
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Authors:  W S Pomat; D Lehmann; R C Sanders; D J Lewis; J Wilson; S Rogers; T Dyke; M P Alpers
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 8.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

9.  A prospective study of inpatients to determine microbial etiology and therapeutic outcome of antibiotics for community-acquired pneumonia in pakistan.

Authors:  Sahar Rehman; Kanwal Rehman; Muhammad Sajid Hamid Akash
Journal:  Bioimpacts       Date:  2013-06-23

10.  Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.

Authors:  Tabish Hazir; Shamim A Qazi; Yasir Bin Nisar; Sajid Maqbool; Rai Asghar; Imran Iqbal; Sobia Khalid; Sajid Randhawa; Shazia Aslam; Sobia Riaz; Saleem Abbasi
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.